Augmentin is used to overcome beta-lactamase resistance. Which statement accurately describes its purpose?

• A. It is a combination of amoxicillin and clavulanic acid to overcome beta-lactamase resistance
• B. It is a combination of amoxicillin and clavulanic acid to increase potency
• C. It is a monotherapy with amoxicillin
• D. It is an antiviral

Answer: (A)

Overcoming beta-lactamase–mediated resistance is achieved by pairing a beta-lactam antibiotic with a beta-lactamase inhibitor. In Augmentin, amoxicillin provides the antibacterial activity against standard susceptible organisms, while clavulanic acid blocks the enzymes that some bacteria produce to inactivate beta-lactam antibiotics. Clavulanic acid binds to beta-lactamase, preventing it from breaking the amoxicillin ring, so the antibiotic can reach its target of inhibiting bacterial cell wall synthesis. This combination broadens the spectrum to include beta-lactamase–producing organisms and restores activity that would be lost with amoxicillin alone. It’s not primarily about increasing potency, it’s about counteracting resistance. It’s also not a monotherapy with just amoxicillin, and it’s not an antiviral.